Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.

http://www.wikidata.org/entity/Q35159185

about

Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease Delayed hippocampal effects from a single exposure of prepubertal guinea pigs to sub-lethal dose of chlorpyrifos: a magnetic resonance imaging and spectroscopy study Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects Microstructural changes in the substantia nigra of asymptomatic agricultural workers Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up.The evolving role of diffusion magnetic resonance imaging in movement disorders MRI reveals brain abnormalities in drug-naive Parkinson's disease.A review of the use of magnetic resonance imaging in Parkinson's disease.Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Longitudinal changes in free-water within the substantia nigra of Parkinson's disease Usefulness of R2* maps generated by iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation sequence for cerebral artery dissection.Free-water imaging in Parkinson's disease and atypical parkinsonism.R2* Map by IDEAL IQ for Acute Cerebral Infarction: Compared with Susceptibility Vessel Sign on T2*-Weighted Imaging.Advanced magnetic resonance imaging of neurodegenerative diseases.The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Targeting chelatable iron as a therapeutic modality in Parkinson's disease.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis.A multicontrast approach for comprehensive imaging of substantia nigra.Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?Parkinson's disease biomarkers program brain imaging repository.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.Imaging nigral pathology and clinical progression in Parkinson's disease.Higher iron in the red nucleus marks Parkinson's dyskinesia.Multimodal Imaging Signatures of Parkinson's Disease.Increased R2* in the Caudate Nucleus of Asymptomatic Welders.Thalamic projection fiber integrity in de novo Parkinson disease.Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease.Brain iron accumulation in aging and neurodegenerative disorders.Magnetic Resonance Imaging (MRI) in Parkinson's Disease.

P2860

Q27316725-CF3A8FCA-8904-474E-974F-D8883604929B Q28383723-385793D4-8BA4-4FFB-82B6-C24FE4080846 Q28395854-0AC1E7E4-07D2-41AD-A26C-B3E11B1166E6 Q28396222-E1A326DB-48AF-49B1-ABC3-C90A4BE55E8A Q28397004-28546DE6-DD37-4C2C-8DE7-99EB84B3F63C Q30457611-923A93A9-5E2B-47E6-845F-6C844F6D3982 Q30667544-6500355D-E580-4A8F-8887-E017A16B4C3E Q30688718-D9B8AC02-A97C-4C99-A6A9-C4504B9A82BF Q30835548-E931859C-BB52-43AB-A4C8-74C69F20AAA1 Q30873974-69C80D75-240B-495D-B86A-0BEB0313CCC6 Q30952963-AD2BD85C-8500-42E3-A925-8DC7477ED258 Q30970801-AFC5FF79-21C2-447B-813C-69ECA664DCDD Q31034031-98F3DF4A-DF24-45F4-A359-CA1B90B1D80C Q31135111-5124B144-877C-46CA-B0D1-D712EE6EE3C1 Q31142517-9597A304-6873-44F6-95AD-90E4E098E592 Q31146333-31DB691F-18D4-4725-8776-B355E816201D Q33768106-9100C7CB-58BC-4200-806F-F65AE040ED51 Q34243731-8A0D0260-5FAB-45AA-9A1B-93493782A7C9 Q34372099-80C9A3C6-DBF3-4EEE-A0AB-12F87E7A2E78 Q34601225-83CE2DCE-F434-4BBD-82F8-E7D09B839053 Q35555926-781DC0DC-CA14-411E-A309-0424A15C08B1 Q35880556-73A2B44C-339E-4491-809F-C5DF0E071B6D Q35976522-C50CA498-8AB9-4EC2-A01D-84D166CC2759 Q36276040-8668087E-A955-462E-B312-AF5CEFA1F923 Q36332532-4D06299A-A468-42D0-BDDF-D3924D61FBDC Q36374541-AF194EDE-80D2-4435-A7E2-15FBC9C0D79D Q36378779-26001365-884A-4F4E-8334-CDF384350CFB Q36434577-973082B2-D403-4DE6-B273-0A174FBEF8CA Q36605028-9CB1E96E-B3AB-4E71-BB86-536443BAB7D3 Q36805798-9622908C-C905-41C3-B844-CA38B70909C5 Q36871031-D5001002-4B48-460E-8C7A-9934853BF25C Q36893101-E1BC04A1-42DB-4CC9-AE03-1DD38B7E20CD Q36902028-CDB88244-79C8-4950-951C-5C6A3F7B82DD Q37106984-270DF551-522B-4FFA-9AAB-6DF49B06E093 Q37204665-D1ADAA18-6647-4471-BB6C-FC7A555AC61E Q37313955-60478268-1221-48EC-A3A0-DF89972127FD Q37558908-1BF318E8-6749-4788-B95B-3E1684A13AB3 Q37737032-4E2A20FB-352C-4C26-BB4C-D9FC8946C8DE Q38067144-6CAF29D7-CFD9-419B-8E85-8A3B6470DD3E Q38281082-1407DA3E-537A-47AB-8235-3AE1D18702E9

P2860

Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.

http://www.wikidata.org/entity/Q35159185

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@ast

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@en

type

label

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@ast

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@en

prefLabel

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@ast

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@en

P1433

Q35159185-AEA31AC4-0F30-4A10-8594-E2BB1040156D

P1476

Q35159185-27C7F197-8043-47D0-A5DC-59205D26608B

P2093

Q35159185-1F243041-6C01-42C2-9540-A33CB3202BFD

Q35159185-57BE0656-286D-47CB-B443-EF8DE8DEE53E

Q35159185-608D58DD-2BE7-4289-BBD3-7E6EE3A1F672

Q35159185-7A762CB6-7010-4584-9754-DC16ECC3F284

Q35159185-8F210CA7-742C-4789-A260-4F2E0DE1EF9B

P2860

Q35159185-00A8B6D3-0991-45A3-9B0E-1CAF99F56BA1

Q35159185-0425E2C4-83C3-434C-9CD7-345BF9AD3D25

Q35159185-04D7358F-A949-4E7F-9C6E-BF15B458A340

Q35159185-1F64F18A-61E9-4C0F-B4CE-B6F6BF633253

Q35159185-28346A4C-0129-4BAA-B9C5-2166FD6A0866

Q35159185-4792D6AA-2B66-40E9-B471-E590E8FF6C8C

Q35159185-69E92131-5C70-4EF8-AB81-FBB8F59E3EE9

Q35159185-8C24B3E4-57B6-4B3C-BC95-E810B964D0E6

Q35159185-8CE811E1-B757-4343-B513-394359075197

Q35159185-9B78A3B8-6602-4B84-98D8-20EC5F9F4EB8

P304

Q35159185-4C789A9F-DFB6-4715-B675-F90767EA182B

P31

Q35159185-94659327-799B-4EDF-AD2D-B590577B6637

P356

Q35159185-CF9CC9A7-AB83-4C9A-9566-7A240844207D

P407

Q35159185-F4A66E35-0F2C-4EA4-AAB7-091DA75E40AA

P433

Q35159185-40E38887-48C3-4CB7-B027-F6C9F12AAF12

P478

Q35159185-53535ED7-14CE-47C4-9D24-3714DDBCB62B

P50

Q35159185-005A9618-D567-43FB-BBF3-EB51DBA57D5D

Q35159185-7EF00473-8326-4859-AFDF-580B36FE0653

P577

Q35159185-8B62B997-098F-42B0-9039-7FF015C58E35

P5875

Q35159185-274AB79A-552E-4065-8D50-52CA5B856CFF

P698

Q35159185-7197CA6C-E9B9-42C1-AEDC-9A778488696A

P921

Q35159185-9947B0F0-42E8-4B4B-8E99-05216C367F70

Q35159185-C1C01A35-2592-41F3-B117-CFEFD0E7744B

P932

Q35159185-B2E94CDF-4EA4-455B-921C-34E72B7814D6

P356

P1433

Movement Disorders

P1476

Combined R2* and diffusion ten ...... nigra in Parkinson's disease.

@en

P2093

Guangwei Du

http://www.w3.org/2001/XMLSchema#string

Mechelle M Lewis

http://www.w3.org/2001/XMLSchema#string

Michele L Shaffer

http://www.w3.org/2001/XMLSchema#string

Qing X Yang

http://www.w3.org/2001/XMLSchema#string

Suman Sen

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI

Advances in functional and structural MR image analysis and implementation as FSL

A global optimisation method for robust affine registration of brain images

Ageing and Parkinson's disease: substantia nigra regional selectivity

User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability

Imaging iron stores in the brain using magnetic resonance imaging.

Principles of diffusion tensor imaging and its applications to basic neuroscience research.

Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging.

Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.

P304

1627-1632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23643

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51170942

http://www.w3.org/2001/XMLSchema#string

P698

21618607

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

substantia nigra

P932

3154471

http://www.w3.org/2001/XMLSchema#string